EGFR and neoplasm: Using Ab-sensitive TUBO (HER2/neu+) and Ab-resistant EGFR-transduced B16 mouse tumor models (Rovero et al.2000), they found increased production of type I IFNs in the Ab-sensitive tumor model, in contrast to the Ab-resistant tumor model.